GP531 - ≥98% , CAS No.142344-87-4

CAS: 142344-87-4 Cat. No.: G647089 Formule: C16H21N5O4 Poids moléculaire: 347.37 PubChem CID: 164444
DISPONIBLE À COMMANDE
GRADE & PURITY ≥98%
Synonyms
5-amino-1-[(2R,3R,4S,5R)-5-[(benzylamino)methyl]-3,4-dihydroxyoxolan-2-yl]imidazole-4-carboxamide | 1H-IMIDAZOLE-4-CARBOXAMIDE, 5-AMINO-1-(5-DEOXY-5-((PHENYLMETHYL)AMINO)-.BETA.-D-RIBOFURANOSYL)- | HY-U00116 | 5-Amino-1-[5-(benzylamino)-5-deoxypentofurano
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
★
Size
Allemagne (EU)
USA*
Price
Qty
5mg
G647089-5mg
Sur commande · 8–12 semaines
937,94€
10mg
G647089-10mg
Sur commande · 8–12 semaines
1 701,55€
50mg
G647089-50mg
Sur commande · 8–12 semaines
4 860,12€
Enter a quantity for the sizes you want to add.
🧪

Why this grade

≥98% for sensitive chromatographic and analytical workflows requiring minimal baseline interference.

🌡

Storage & shipping

Store at -20°C Ships Ice chest + Ice pads Check lot-specific COA for exact specifications.

📋

Quality documents

SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.

📚

Literature proof

Cited in 0 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.

Vue d’ensemble

GP531 is a potent, second-generation adenosine regulating agent, is pharmacologically silent under basal conditions but increases localized endogenous adenosine during ischemia.

In Vivo

Low-dose GP531 reduces infarct size by 34% compared with vehicle and reduces the extent of the anatomic no-reflow zone by 31% compared with vehicle. Infarct size and zone of no-reflow in the high dose are reduced by 22% and 16%, respectively. GP531 does not affect hemodynamics or blood flow. GP531 is effective at the lower dose in reducing the severity of ischemic/reperfusion injury, without inducing the adverse hemodynamic effects associated with adenosine administration such as bradycardia and hypotension . GP531 infusion has no effect on heart rate or mean aortic pressure but significantly decreases left ventricular end-diastolic pressure, end-diastolic volume, end-systolic volume and end-diastolic wall stress. GP531 significantly increases left ventricular EF, deceleration time of early mitral inflow velocity and the slope of end-systolic PVR without increasing MVO2. MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Form:Solid

IC50& Target:Adenosine Receptor

Specifications

Synonymes
5-amino-1-[(2R,3R,4S,5R)-5-[(benzylamino)methyl]-3,4-dihydroxyoxolan-2-yl]imidazole-4-carboxamide | 1H-IMIDAZOLE-4-CARBOXAMIDE, 5-AMINO-1-(5-DEOXY-5-((PHENYLMETHYL)AMINO)-.BETA.-D-RIBOFURANOSYL)- | HY-U00116 | 5-Amino-1-[5-(benzylamino)-5-deoxypentofurano
Spécifications et pureté
≥98%
Mécanismes biochimiques et physiologiques
GP531 is a potent, second-generation adenosine regulating agent, is pharmacologically silent under basal conditions but increases localized endogenous adenosine during ischemia.
Conditions de stockage de stockage
Store at -20°C
Expédié en
Ice chest + Ice pads
Ce produit nécessite l'expédition en chaîne froide. Les services terrestres et autres services économiques ne sont pas disponibles.
Type d'action
MODULATOR
Pureté
≥98%
Noms et identifiants
Sourires canoniquesC1=CC=C(C=C1)CNCC2C(C(C(O2)N3C=NC(=C3N)C(=O)N)O)O
IUPAC Name5-amino-1-[(2R,3R,4S,5R)-5-[(benzylamino)methyl]-3,4-dihydroxyoxolan-2-yl]imidazole-4-carboxamide
InChIKeyLECUGLHMNZTZQB-XNIJJKJLSA-N
INCHI1S/C16H21N5O4/c17-14-11(15(18)24)20-8-21(14)16-13(23)12(22)10(25-16)7-19-6-9-4-2-1-3-5-9/h1-5,8,10,12-13,16,19,22-23H,6-7,17H2,(H2,18,24)/t10-,12-,13-,16-/m1/s1
Isomères SMILES C1=CC=C(C=C1)CNC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=NC(=C3N)C(=O)N)O)O
CAS alternatif 142344-87-4
PubChem CID 164444
Termes d'entrée MeSH 5-amino-1-beta-D-(5'-benzylamino-5'-deoxyribofuranosyl)imidazole-4-carboxamide;GP 531;GP-531;GP531
Poids moléculaire 347.37

Documentation

📋 Safety Data Sheet (SDS)

Comprehensive hazard, handling, storage, and regulatory compliance document.

Download SDS →

✅ Certificate of Analysis (COA)

Lot-specific quality data. Enter your lot number to retrieve the exact COA.

Look up COA →

📊 Datasheet

Quick-reference summary of product specifications and applications.

View datasheet →

🔬 Specification Sheet

Full quality attributes and acceptance criteria for this grade.

View spec sheet →

Advanced Data

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassOrganic oxygen compounds
ClasseOrganooxygen compounds
SubclassCarbohydrates and carbohydrate conjugates
Intermediate Tree Nodes Glycosyl compounds
Direct ParentGlycosylamines
Alternative Parents Pentoses  Phenylmethylamines  Benzylamines  2-heteroaryl carboxamides  Carbonylimidazoles  Aralkylamines  N-substituted imidazoles  Aminoimidazoles  Vinylogous amides  Tetrahydrofurans  Heteroaromatic compounds  Secondary alcohols  Primary carboxylic acid amides  Amino acids and derivatives  1,2-diols  Oxacyclic compounds  Dialkylamines  Azacyclic compounds  Primary amines  Organopnictogen compounds  Organic oxides  Hydrocarbon derivatives  
Molecular FrameworkAromatic heteromonocyclic compounds
Substituents N-glycosyl compound - Pentose monosaccharide - 2-heteroaryl carboxamide - Phenylmethylamine - Benzylamine - Aralkylamine - Imidazole-4-carbonyl group - Benzenoid - N-substituted imidazole - Monosaccharide - Monocyclic benzene moiety - Aminoimidazole - Heteroaromatic compound - Vinylogous amide - Tetrahydrofuran - Imidazole - Azole - Secondary alcohol - Primary carboxylic acid amide - Carboxamide group - Amino acid or derivatives - 1,2-diol - Oxacycle - Azacycle - Organoheterocyclic compound - Secondary amine - Secondary aliphatic amine - Carboxylic acid derivative - Organic nitrogen compound - Organopnictogen compound - Organic oxide - Hydrocarbon derivative - Primary amine - Organonitrogen compound - Amine - Alcohol - Aromatic heteromonocyclic compound
DescriptionThis compound belongs to the class of organic compounds known as glycosylamines. These are compounds consisting of an amine with a beta-N-glycosidic bond to a carbohydrate, thus forming a cyclic hemiaminal ether bond (alpha-amino ether).
External Descriptors Not available
Structure 3D
Modèle de structure chimique interactif





Certificats (CoA, COO, BSE/TSE et tableau d'analyse)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Propriétés chimiques et physiques
SolubilitéDMSO : 125 mg/mL (359.85 mM; Need ultrasonic)
Poids moléculaire347.370 g/mol
XLogP3-0.400
Hydrogen Bond Donor Count5
Hydrogen Bond Acceptor Count7
Rotatable Bond Count6
Exact Mass347.159 Da
Monoisotopic Mass347.159 Da
Topological Polar Surface Area149.000 Ų
Heavy Atom Count25
Formal Charge0
Complexity462.000
Isotope Atom Count0
Defined Atom Stereocenter Count4
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count1
Calculateurs de solution
Avis

Avis des clients

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.